STBT5:Volunteer Assignments and Opportunities: Difference between revisions
Jump to navigation
Jump to search
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br /> | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br /> | ||
__TOC__ | |||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big> | |+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big> | ||
| Line 16: | Line 17: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
| | | | ||
====CHAPTER 2 (SOFT TISSUE TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 54: | Line 41: | ||
|[[STBT5:Lipoma|Lipoma]] | |[[STBT5:Lipoma|Lipoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 70: | Line 52: | ||
|[[STBT5:Lipomatosis|Lipomatosis]] | |[[STBT5:Lipomatosis|Lipomatosis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 86: | Line 63: | ||
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]] | |[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 102: | Line 74: | ||
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]] | |[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 118: | Line 85: | ||
|[[STBT5:Angiolipoma_|Angiolipoma]] | |[[STBT5:Angiolipoma_|Angiolipoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 134: | Line 96: | ||
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]] | |[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 150: | Line 107: | ||
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]] | |[[STBT5:Chondroid_lipoma|Chondroid lipoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 166: | Line 118: | ||
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]] | |[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 182: | Line 129: | ||
|[[STBT5:Hibernoma|Hibernoma]] | |[[STBT5:Hibernoma|Hibernoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 206: | Line 148: | ||
| | | | ||
| | | | ||
| | |- | ||
| | |- | ||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |- | ||
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]] | |[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 230: | Line 171: | ||
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]] | |[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 246: | Line 182: | ||
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]] | |[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 262: | Line 193: | ||
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]] | |[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 278: | Line 204: | ||
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]] | |[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 294: | Line 215: | ||
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]] | |[[STBT5:Nodular_fasciitis|Nodular fasciitis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 315: | Line 231: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 324: | Line 246: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 333: | Line 255: | ||
| | | | ||
| | | | ||
| | |||
|- | |||
|[[STBT5:Elastofibroma|Elastofibroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 339: | Line 265: | ||
| | | | ||
| | | | ||
| | |||
| | |||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |- | ||
|[[STBT5: | |[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 350: | Line 287: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 363: | Line 298: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 372: | Line 310: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 382: | Line 320: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 395: | Line 331: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 404: | Line 343: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Myofibroblastoma|Myofibroblastoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 420: | Line 354: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 436: | Line 365: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 452: | Line 376: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 459: | Line 383: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 468: | Line 407: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 478: | Line 417: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 491: | Line 428: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 500: | Line 440: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Gardner_fibroma|Gardner fibroma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 507: | Line 447: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 516: | Line 462: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 532: | Line 473: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Lipofibromatosis|Lipofibromatosis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 548: | Line 484: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 564: | Line 495: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 574: | Line 505: | ||
| | | | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |- | ||
|Disease | !'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | ||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | |||
|Disease | |||
|Shashi Shetty and Reba Daniel (resident) | |||
|2/21/2024 | |||
| | |||
|PENDING | |||
| | | | ||
|Katherine Geiersbach | |||
| | | | ||
|Template added 2/21/2024 | |||
|- | |||
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 592: | Line 536: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 603: | Line 547: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 612: | Line 559: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 622: | Line 569: | ||
| | | | ||
| | | | ||
| | |- | ||
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]] | |||
|Disease | |||
|Katie Schieffer | |||
|4/21/2025 | |||
|10/1/2025 | |||
|PENDING | |||
| | | | ||
| | | | ||
| Line 628: | Line 581: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 638: | Line 591: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 651: | Line 602: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 660: | Line 614: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 670: | Line 624: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 675: | Line 641: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 689: | Line 655: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]] | |||
|- | |||
|[[STBT5: | |||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 708: | Line 667: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 718: | Line 677: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 731: | Line 688: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 740: | Line 700: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 750: | Line 710: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Venous_haemangioma|Venous haemangioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 755: | Line 718: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 768: | Line 731: | ||
| | | | ||
| | | | ||
| | |||
|- | |||
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 779: | Line 743: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 788: | Line 764: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 798: | Line 774: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 811: | Line 785: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 820: | Line 797: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 836: | Line 808: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 852: | Line 819: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 868: | Line 830: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 884: | Line 841: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Angiosarcoma|Angiosarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 894: | Line 851: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Glomus_tumour|Glomus tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 907: | Line 862: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 916: | Line 883: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Angioleiomyoma|Angioleiomyoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 926: | Line 893: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Leiomyoma|Leiomyoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 931: | Line 901: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 945: | Line 915: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 955: | Line 925: | ||
| | | | ||
| | | | ||
| | |||
|- | |||
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 964: | Line 938: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Rhabdomyoma|Rhabdomyoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 974: | Line 948: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 987: | Line 959: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 996: | Line 971: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,006: | Line 981: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,019: | Line 1,001: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,028: | Line 1,013: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,038: | Line 1,023: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,051: | Line 1,034: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,060: | Line 1,046: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Schwannoma|Schwannoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,070: | Line 1,056: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Neurofibroma|Neurofibroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,083: | Line 1,067: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Perineurioma|Perineurioma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,092: | Line 1,079: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Granular_cell_tumour|Granular cell tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,099: | Line 1,086: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,108: | Line 1,101: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |- | ||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]] | |||
|Disease | |Disease | ||
| | | | ||
| Line 1,115: | Line 1,117: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,124: | Line 1,132: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,134: | Line 1,142: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,147: | Line 1,153: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,156: | Line 1,165: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,163: | Line 1,172: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,172: | Line 1,187: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,182: | Line 1,197: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,195: | Line 1,208: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,204: | Line 1,220: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |- | ||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]] | |||
|Disease | |Disease | ||
| | | | ||
| Line 1,211: | Line 1,236: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,220: | Line 1,251: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,230: | Line 1,261: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,243: | Line 1,272: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,252: | Line 1,284: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,262: | Line 1,294: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]] | |||
|Disease | |||
|James Solomon, MD, PhD | |||
|2/20/2022 | |||
|12/9/2025 | |||
|PENDING | |||
| | | | ||
| | |Katie Schieffer | ||
| | | | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Synovial_sarcoma|Synovial sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 1,284: | Line 1,317: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,291: | Line 1,324: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,300: | Line 1,339: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,310: | Line 1,349: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,323: | Line 1,369: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,332: | Line 1,381: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,339: | Line 1,388: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:PEComa|PEComa]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,348: | Line 1,403: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Intimal_sarcoma|Intimal sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,358: | Line 1,413: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,363: | Line 1,421: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
| | | | ||
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)==== | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
|- | |- | ||
|[[STBT5: | |[[STBT5:Ewing_sarcoma|Ewing sarcoma]] | ||
|Disease | |Disease | ||
|Sadeem Qdaisat | |||
|10/1/23 | |||
|12/9/2025 | |||
|PENDING | |||
| | | | ||
|Working with Eric McGinnis | |||
| | | | ||
|2021 template added | |||
|- | |||
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,392: | Line 1,467: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | |||
|Disease | |||
|Ganesh Pandurang, MD | |||
|2/28/24 | |||
| | | | ||
|PENDING | |||
| | |||
|Katherine Geiersbach | |||
| | | | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,406: | Line 1,489: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
| | | | ||
====CHAPTER 4 (BONE TUMOURS)==== | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
|- | |||
|[[STBT5:Subungual_exostosis|Subungual exostosis]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,428: | Line 1,531: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,435: | Line 1,538: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,444: | Line 1,553: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Enchondroma|Enchondroma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,454: | Line 1,563: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Osteochondroma|Osteochondroma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,467: | Line 1,574: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Chondroblastoma|Chondroblastoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,476: | Line 1,586: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,486: | Line 1,596: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,499: | Line 1,607: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,508: | Line 1,619: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,518: | Line 1,629: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,531: | Line 1,640: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,540: | Line 1,661: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,550: | Line 1,671: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,563: | Line 1,682: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,572: | Line 1,694: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,582: | Line 1,704: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,595: | Line 1,715: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Osteoma|Osteoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,604: | Line 1,727: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Osteoid_osteoma_|Osteoid osteoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,614: | Line 1,737: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Osteoblastoma_|Osteoblastoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,627: | Line 1,748: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,636: | Line 1,760: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |- | ||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Osteosarcoma|Osteosarcoma]] | |||
|Disease | |Disease | ||
| | | | ||
| Line 1,646: | Line 1,779: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,659: | Line 1,790: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,668: | Line 1,802: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,678: | Line 1,812: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,691: | Line 1,823: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,700: | Line 1,835: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,710: | Line 1,845: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,715: | Line 1,853: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,728: | Line 1,866: | ||
| | | | ||
| | | | ||
| | |||
|- | |||
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,739: | Line 1,878: | ||
| | | | ||
| | | | ||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,748: | Line 1,899: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,764: | Line 1,910: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 1,780: | Line 1,921: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,790: | Line 1,931: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,803: | Line 1,942: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Conventional_chordoma|Conventional chordoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,812: | Line 1,954: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 1,828: | Line 1,965: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 1,844: | Line 1,976: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 1,860: | Line 1,987: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,867: | Line 1,994: | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | |||
|- | |||
|- | |||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |||
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,876: | Line 2,018: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Simple_bone_cyst|Simple bone cyst]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,886: | Line 2,028: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,899: | Line 2,039: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,908: | Line 2,051: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,918: | Line 2,061: | ||
| | | | ||
| | | | ||
|- | |||
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]] | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,923: | Line 2,069: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
- | |- | ||
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]] | |||
|Disease | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Bone_metastases|Bone metastases]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,970: | Line 2,095: | ||
| | | | ||
|- | |- | ||
|[[STBT5: | |[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,979: | Line 2,104: | ||
| | | | ||
| | | | ||
| | |||
|- | |||
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]] | |||
|Disease | |||
| | |||
|- | |||
|[[STBT5: | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 2,002: | Line 2,117: | ||
| | | | ||
|- | |- | ||
|- | |- | ||
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | |||
!'''Date Assigned to Author''' | |||
!'''Target Completion Date''' | |||
!'''Author Content (Pending or Complete)''' | |||
!'''Date Completed by Author'''!!'''Associate Editor''' | |||
!'''Date of Last Editor Review''' | |||
!'''Notes''' | |||
|- | |- | ||
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]] | |[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 2,882: | Line 2,139: | ||
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]] | |[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 2,898: | Line 2,150: | ||
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | |[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 2,912: | Line 2,159: | ||
| | | | ||
|- | |- | ||
| | | | ||
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)==== | |||
| | | | ||
---- | ---- | ||
| Line 2,944: | Line 2,182: | ||
|[[STBT5:Enchondromatosis|Enchondromatosis]] | |[[STBT5:Enchondromatosis|Enchondromatosis]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 2,960: | Line 2,193: | ||
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | |[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]] | |[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 2,992: | Line 2,215: | ||
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]] | |[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 3,008: | Line 2,226: | ||
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | |[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]] | |[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| Line 3,040: | Line 2,248: | ||
|[[STBT5:Werner_syndrome|Werner syndrome]] | |[[STBT5:Werner_syndrome|Werner syndrome]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
Latest revision as of 17:31, 9 September 2025
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (SOFT TISSUE TUMOURS) |
|
|
|
|
|
|
|
|
|
| Lipoma | Disease | ||||||||
| Lipomatosis | Disease | ||||||||
| Lipomatosis of nerve | Disease | ||||||||
| Lipoblastoma and lipoblastomatosis | Disease | ||||||||
| Angiolipoma | Disease | ||||||||
| Myolipoma of soft tissue | Disease | ||||||||
| Chondroid lipoma | Disease | ||||||||
| Spindle cell lipoma and pleomorphic lipoma | Disease | ||||||||
| Hibernoma | Disease | ||||||||
| Atypical spindle cell / pleomorphic lipomatous tumour | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Atypical lipomatous tumour / well-differentiated liposarcoma | Disease | ||||||||
| Dedifferentiated liposarcoma | Disease | ||||||||
| Myxoid liposarcoma | Disease | ||||||||
| Pleomorphic liposarcoma | Disease | ||||||||
| Myxoid pleomorphic liposarcoma | Disease | ||||||||
| Nodular fasciitis | Disease | ||||||||
| Proliferative fasciitis and proliferative myositis | Disease | ||||||||
| Myositis ossificans and fibro-osseous pseudotumour of digits | Disease | ||||||||
| Ischaemic fasciitis | Disease | ||||||||
| Elastofibroma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Fibrous hamartoma of infancy | Disease | ||||||||
| Fibromatosis colli | Disease | ||||||||
| Juvenile hyaline fibromatosis | Disease | ||||||||
| Inclusion body fibromatosis | Disease | ||||||||
| Fibroma of tendon sheath | Disease | ||||||||
| Desmoplastic fibroblastoma | Disease | ||||||||
| Myofibroblastoma | Disease | ||||||||
| Calcifying aponeurotic fibroma | Disease | ||||||||
| EWSR1-SMAD3-positive fibroblastic tumour (emerging) | Disease | ||||||||
| Angiomyofibroblastoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Cellular angiofibroma | Disease | ||||||||
| Angiofibroma of soft tissue | Disease | ||||||||
| Nuchal-type fibroma | Disease | ||||||||
| Acral fibromyxoma | Disease | ||||||||
| Gardner fibroma | Disease | ||||||||
| Palmar fibromatosis and plantar fibromatosis | Disease | ||||||||
| Desmoid fibromatosis | Disease | ||||||||
| Lipofibromatosis | Disease | ||||||||
| Giant cell fibroblastoma | Disease | ||||||||
| Dermatofibrosarcoma protuberans | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Solitary fibrous tumour | Disease | Shashi Shetty and Reba Daniel (resident) | 2/21/2024 | PENDING | Katherine Geiersbach | Template added 2/21/2024 | |||
| Inflammatory myofibroblastic tumour | Disease | ||||||||
| Low-grade myofibroblastic sarcoma | Disease | ||||||||
| Superficial CD34-positive fibroblastic tumour | Disease | ||||||||
| Myxoinflammatory fibroblastic sarcoma | Disease | ||||||||
| Infantile fibrosarcoma | Disease | Katie Schieffer | 4/21/2025 | 10/1/2025 | PENDING | ||||
| Adult fibrosarcoma | Disease | ||||||||
| Myxofibrosarcoma | Disease | ||||||||
| Low-grade fibromyxoid sarcoma | Disease | ||||||||
| Sclerosing epithelioid fibrosarcoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Tenosynovial giant cell tumour | Disease | ||||||||
| Deep fibrous histiocytoma | Disease | ||||||||
| Plexiform fibrohistiocytic tumour | Disease | ||||||||
| Giant cell tumour of soft tissue | Disease | ||||||||
| Synovial haemangioma | Disease | ||||||||
| Intramuscular angioma | Disease | ||||||||
| Arteriovenous malformation/haemangioma | Disease | ||||||||
| Venous haemangioma | Disease | ||||||||
| Anastomosing haemangioma | Disease | ||||||||
| Epithelioid haemangioma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Lymphangioma and lymphangiomatosis | Disease | ||||||||
| Tufted angioma and kaposiform haemangioendothelioma | Disease | ||||||||
| Retiform haemangioendothelioma | Disease | ||||||||
| Papillary intralymphatic angioendothelioma | Disease | ||||||||
| Composite haemangioendothelioma | Disease | ||||||||
| Kaposi sarcoma | Disease | ||||||||
| Pseudomyogenic haemangioendothelioma | Disease | ||||||||
| Epithelioid haemangioendothelioma | Disease | ||||||||
| Angiosarcoma | Disease | ||||||||
| Glomus tumour | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Myopericytoma, including myofibroma | Disease | ||||||||
| Angioleiomyoma | Disease | ||||||||
| Leiomyoma | Disease | ||||||||
| EBV-associated smooth muscle tumour | Disease | ||||||||
| Inflammatory leiomyosarcoma | Disease | ||||||||
| Leiomyosarcoma | Disease | ||||||||
| Rhabdomyoma | Disease | ||||||||
| Embryonal rhabdomyosarcoma | Disease | ||||||||
| Alveolar rhabdomyosarcoma | Disease | ||||||||
| Pleomorphic rhabdomyosarcoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Spindle cell / sclerosing rhabdomyosarcoma | Disease | ||||||||
| Ectomesenchymoma | Disease | ||||||||
| Gastrointestinal stromal tumour | Disease | ||||||||
| Soft tissue chondroma | Disease | ||||||||
| Extraskeletal osteosarcoma | Disease | ||||||||
| Schwannoma | Disease | ||||||||
| Neurofibroma | Disease | ||||||||
| Perineurioma | Disease | ||||||||
| Granular cell tumour | Disease | ||||||||
| Dermal nerve sheath myxoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Solitary circumscribed neuroma | Disease | ||||||||
| Ectopic meningioma and meningothelial hamartoma | Disease | ||||||||
| Benign triton tumour / neuromuscular choristoma | Disease | ||||||||
| Hybrid nerve sheath tumour | Disease | ||||||||
| Malignant peripheral nerve sheath tumour | Disease | ||||||||
| Malignant melanotic nerve sheath tumour | Disease | ||||||||
| Intramuscular myxoma | Disease | ||||||||
| Juxta-articular myxoma | Disease | ||||||||
| Deep (aggressive) angiomyxoma | Disease | ||||||||
| Atypical fibroxanthoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Angiomatoid fibrous histiocytoma | Disease | ||||||||
| Ossifying fibromyxoid tumour | Disease | ||||||||
| Myoepithelioma, myoepithelial carcinoma, and mixed tumour | Disease | ||||||||
| Pleomorphic hyalinizing angiectatic tumour of soft parts | Disease | ||||||||
| Haemosiderotic fibrolipomatous tumour | Disease | ||||||||
| Phosphaturic mesenchymal tumour | Disease | ||||||||
| NTRK-rearranged spindle cell neoplasm (emerging) | Disease | James Solomon, MD, PhD | 2/20/2022 | 12/9/2025 | PENDING | Katie Schieffer | |||
| Synovial sarcoma | Disease | ||||||||
| Epithelioid sarcoma | Disease | ||||||||
| Alveolar soft part sarcoma | Disease | ||||||||
| Clear cell sarcoma of soft tissue | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Extraskeletal myxoid chondrosarcoma | Disease | ||||||||
| Desmoplastic small round cell tumour | Disease | ||||||||
| Extrarenal rhabdoid tumour | Disease | ||||||||
| PEComa | Disease | ||||||||
| Intimal sarcoma | Disease | ||||||||
| Undifferentiated sarcoma | Disease | ||||||||
CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE) |
|
|
|
|
|
|
|
|
|
| Ewing sarcoma | Disease | Sadeem Qdaisat | 10/1/23 | 12/9/2025 | PENDING | Working with Eric McGinnis | 2021 template added | ||
| Round cell sarcoma with EWSR1-non-ETS fusions | Disease | ||||||||
| CIC-rearranged sarcoma | Disease | Ganesh Pandurang, MD | 2/28/24 | PENDING | Katherine Geiersbach | ||||
| Sarcoma with BCOR genetic alterations | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
CHAPTER 4 (BONE TUMOURS) |
|
|
|
|
|
|
|
|
|
| Subungual exostosis | Disease | ||||||||
| Bizarre parosteal osteochondromatous proliferation | Disease | ||||||||
| Periosteal chondroma | Disease | ||||||||
| Enchondroma | Disease | ||||||||
| Osteochondroma | Disease | ||||||||
| Chondroblastoma | Disease | ||||||||
| Chondromyxoid fibroma | Disease | ||||||||
| Osteochondromyxoma | Disease | ||||||||
| Synovial chondromatosis | Disease | ||||||||
| Central atypical cartilaginous tumour / chondrosarcoma, grade 1 | Disease | ||||||||
| Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Central chondrosarcoma, grades 2 and 3 | Disease | ||||||||
| Secondary peripheral chondrosarcoma, grades 2 and 3 | Disease | ||||||||
| Periosteal chondrosarcoma | Disease | ||||||||
| Clear cell chondrosarcoma | Disease | ||||||||
| Mesenchymal chondrosarcoma | Disease | ||||||||
| Dedifferentiated chondrosarcoma | Disease | ||||||||
| Osteoma | Disease | ||||||||
| Osteoid osteoma | Disease | ||||||||
| Osteoblastoma | Disease | ||||||||
| Low-grade central osteosarcoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Osteosarcoma | Disease | ||||||||
| Parosteal osteosarcoma | Disease | ||||||||
| Periosteal osteosarcoma | Disease | ||||||||
| High-grade surface osteosarcoma | Disease | ||||||||
| Secondary osteosarcoma | Disease | ||||||||
| Desmoplastic fibroma of bone | Disease | ||||||||
| Fibrosarcoma of bone | Disease | ||||||||
| Haemangioma of bone | Disease | ||||||||
| Epithelioid haemangioma of bone | Disease | ||||||||
| Epithelioid haemangioendothelioma of bone | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Angiosarcoma of bone | Disease | ||||||||
| Aneurysmal bone cyst | Disease | ||||||||
| Giant cell tumour of bone | Disease | ||||||||
| Non-ossifying fibroma | Disease | ||||||||
| Benign notochordal cell tumour | Disease | ||||||||
| Conventional chordoma | Disease | ||||||||
| Dedifferentiated chordoma | Disease | ||||||||
| Poorly differentiated chordoma | Disease | ||||||||
| Chondromesenchymal hamartoma of chest wall | Disease | ||||||||
| Osteofibrous dysplasia | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Adamantinoma of long bones | Disease | ||||||||
| Simple bone cyst | Disease | ||||||||
| Fibrocartilaginous mesenchymoma | Disease | ||||||||
| Fibrous dysplasia | Disease | ||||||||
| Lipoma and hibernoma of bone | Disease | ||||||||
| Leiomyosarcoma of bone | Disease | ||||||||
| Undifferentiated pleomorphic sarcoma | Disease | ||||||||
| Bone metastases | Disease | ||||||||
| Solitary plasmacytoma of bone | Disease | ||||||||
| Primary non-Hodgkin lymphoma of bone | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Langerhans cell histiocytosis | Disease | ||||||||
| Erdheim-Chester disease | Disease | ||||||||
| Rosai-Dorfman disease | Disease | ||||||||
CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE) |
|
|
|
|
|
|
|
|
|
| Enchondromatosis | Disease | ||||||||
| Li-Fraumeni syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| McCune-Albright syndrome | Disease | ||||||||
| Multiple osteochondromas | Disease | ||||||||
| Neurofibromatosis type 1 | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Rothmund-Thomson syndrome | Disease | ||||||||
| Werner syndrome | Disease |